Nanogen asked to provide more data of homegrown Nano Covax

Updated at 11:00:07 08/30/2021 (Views: 2591)

Nanogen Pharmaceutical Biotechnology JSC has been asked to provide more data for consideration before a registration certificate of conditional circulation for its Nano Covax can be granted.

Support online Hotline: 0918680377 - 0623604533
Online total: 14762833
Sponsored links: